The revised protocol for the post-approval study (pas)
Device | VICI VENOUS STENT System |
Generic Name | Stent, Iliac Vein |
Applicant | Boston Scientific Corporation |
Date Received | 2020-04-09 |
Decision Date | 2020-05-26 |
PMA | P180013 |
Supplement | S005 |
Product Code | QAN |
Advisory Committee | Cardiovascular |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Postapproval Study Protocol - Ode/oir |
Expedited Review | No |
Combination Product | No |
Applicant Address | Boston Scientific Corporation 300 Boston Scientific Way marlborough, MA 01752 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P180013 | | Original Filing |
S007 |
2021-04-06 |
Normal 180 Day Track No User Fee |
S006 |
2020-07-22 |
Normal 180 Day Track No User Fee |
S005 |
2020-04-09 |
Normal 180 Day Track No User Fee |
S004 | | |
S003 |
2019-11-21 |
30-day Notice |
S002 | | |
S001 |
2019-10-11 |
30-day Notice |
NIH GUDID Devices